Search Results - Rezagholizadeh, Afra

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    SARS-CoV-2 and probable lung cancer risk

    SARS-CoV-2 and probable lung cancer risk by Khiali, Sajad, Rezagholizadeh, Afra, Entezari-Maleki, Taher

    Published in Bioimpacts
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial

    Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary inter... by Khiali, Sajad, Taban-Sadeghi, Mohammadreza, Sarbakhsh, Parvin, Khezerlouy-Aghdam, Naser, Namdar, Hossein, Salehi, Rezvanieh, Rezagholizadeh, Afra, Entezari-Maleki, Taher

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis

    Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis by Rezagholizadeh, Afra, Khiali, Sajad, Sarbakhsh, Parvin, Entezari-Maleki, Taher

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Current evidence of COVID-19 vaccination-related cardiovascular events

    Current evidence of COVID-19 vaccination-related cardiovascular events by Khiali, Sajad, Rezagholizadeh, Afra, Behzad, Hossein, Bannazadeh Baghi, Hossein, Entezari-Maleki, Taher

    Published in Postgraduate medicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    SGLT2 Inhibitors' Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review

    SGLT2 Inhibitors' Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review by Khiali, Sajad, Taban-Sadeghi, Mohammadreza, Sarbakhsh, Parvin, Khezerlouy-Aghdam, Naser, Rezagholizadeh, Afra, Asham, Hila, Entezari-Maleki, Taher

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: